Publication:
Parathyroid carcinoma

Simple item page
dc.contributor.authorWongwattana P.
dc.contributor.authorWiriyaamornchai P.
dc.date.accessioned2022-03-10T13:16:36Z
dc.date.available2022-03-10T13:16:36Z
dc.date.issued2021
dc.date.issuedBE2564
dc.description.abstractParathyroid carcinoma is a very rare cancer, accounting for 0.5% to 5% of all causes of primary hyperparathyroidism. Parathyroid carcinoma has an equal frequency of occurrence in both genders, usually in the fifth decade of life. Preoperative diagnosis of parathyroid carcinoma is difficult due to a lack of clinical findings, laboratory results, or radiological characteristics specific to the disease. Though, parathyroid carcinoma patients usually present with severe hypercalcemia at the time of diagnosis. Complete en-bloc resection is the mainstay of the treatment. The adjuvant therapy such as radiotherapy or chemotherapy has not shown effective in the treatment of parathyroid carcinoma. © JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 2021.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of the Medical Association of Thailand. Vol 104, No.9 (2021), p.S83-S90
dc.identifier.doi10.35755/jmedassocthai.2021.S03.00004
dc.identifier.issn1252208
dc.identifier.other2-s2.0-85116009372
dc.identifier.urihttps://hdl.handle.net/20.500.14740/3872
dc.language.isoeng
dc.rights.holderScopus
dc.subject.otherAlkaline phosphatase
dc.subject.otherBisphosphonic acid derivative
dc.subject.otherCalcitonin
dc.subject.otherDacarbazine
dc.subject.otherDenosumab
dc.subject.otherDoxorubicin
dc.subject.otherFluorouracil
dc.subject.otherLomustine
dc.subject.otherMethotrexate
dc.subject.otherMethoxy isobutyl isonitrile technetium tc 99m
dc.subject.otherSorafenib
dc.subject.otherAdjuvant therapy
dc.subject.otherAkt/mTOR signaling
dc.subject.otherAnorexia
dc.subject.otherCancer staging
dc.subject.otherCell proliferation
dc.subject.otherComputer assisted tomography
dc.subject.otherData base
dc.subject.otherDisease classification
dc.subject.otherDistant metastasis
dc.subject.otherEchography
dc.subject.otherEn bloc resection
dc.subject.otherEnd stage renal disease
dc.subject.otherEnvironmental factor
dc.subject.otherFine needle aspiration biopsy
dc.subject.otherGene mutation
dc.subject.otherHistology
dc.subject.otherHistopathology
dc.subject.otherHuman
dc.subject.otherHypercalcemia
dc.subject.otherHyperparathyroidism
dc.subject.otherHypoparathyroidism
dc.subject.otherImmunohistochemistry
dc.subject.otherJaw tumor
dc.subject.otherLung metastasis
dc.subject.otherLymph node metastasis
dc.subject.otherMonotherapy
dc.subject.otherMorbidity
dc.subject.otherNuclear magnetic resonance imaging
dc.subject.otherParathyroid adenoma
dc.subject.otherParathyroid carcinoma
dc.subject.otherParathyroid hyperplasia
dc.subject.otherPathogenesis
dc.subject.otherPathology
dc.subject.otherPolydipsia
dc.subject.otherPolyuria
dc.subject.otherPositron emission tomography
dc.subject.otherPositron emission tomography-computed tomography
dc.subject.otherReview
dc.subject.otherScintigraphy
dc.subject.otherTreatment response
dc.subject.otherTumor invasion
dc.subject.otherTumor suppressor gene
dc.subject.otherTumor volume
dc.subject.otherVomiting
dc.subject.otherWeakness
dc.titleParathyroid carcinoma
dc.typeReview
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85116009372&doi=10.35755%2fjmedassocthai.2021.S03.00004&partnerID=40&md5=e1646f8f7f3b3a068ca907cb44d57983

Files

Collections

Scopus: Year 1983-2021